Last week was jam-packed with three industry events back-to-back. Curavit, like many of others in our industry, attended all three – CNS Summit, DTRA Inaugural Summit, and Outsourcing in Clinical Trials, New England the week of Nov 7. We had the benefit of speaking andidly with clinical research stakeholders from across the ecosystem, from technology providers to sponsors and CROs.
One of the most unexpected takeaways was the feelings of frustration from sponsors who are ready to move on from “talking about improving clinical trials with software” to “actually improving clinical trials with a new set of solutions.”
In fact, one large pharmaceutical company spokesperson said, “It’s not a platform, but a process. Companies seem to be just selling software.” Another remarked, “The approach to DCTs feels like we’re in a bubble.” Still another did not mince words when he said,”This is all BS. Vendors say that it is all rosy, but it is not.”
